Health Tech Executive.
Commercial Product Leader.

I build AI-native platforms, high-performing product teams, and the operating foundations that move healthcare forward. With 20+ years across provider, payer, and pharma, I translate complex vision into execution that sticks.

35+
Product Org Built
2x
Revenue Growth
$150M
Oncology P&L
20+
Years Leadership
Melissa Honour

Market Coverage

🏥

Provider

Deep roots in clinical workflow and EHR ecosystems. Expert in translating clinical necessity into high-adoption technology.

🛡️

Payer

Scaling AI platforms that reduce administrative waste and improve health plan intelligence for national payers.

🔬

Pharma

Commercialization of product offerings across the complete pharmaceutical value chain—Discovery, Development, Launch, and Market—specializing in Oncology.

Career Milestones

Innovation & R&D

Founder, Airloom Health

Architecting a consumer-centric data liquidity platform designed to empower individuals to share health data with purpose. Leveraging AI-native workflows and decentralized data patterns to solve fragmented care coordination in high-complexity sectors like dementia and chronic disease.

2024 — 2026

VP, Head of Product & Innovation, Stellarus

Built and launched a 0-1 AI-native product organization. Defined the commercial product roadmap, secured two health plan investors, and managed a $20M operating budget.

2022 — 2023

Chief Product Officer, Aster Insights

Defined product strategy and go-to-market execution for a CD&R and Merck-backed Oncology Real-World Data company, leading to a successful acquisition by Zephyr AI.

2019 — 2022

VP, Product Management, McKesson

Owned P&L for a $150M oncology portfolio. Scaled the product team from 8 to 25, achieved 2x growth, and drove a 150% improvement in client adoption.

Thought Leadership

Featured in BU School of Public Health

"From MPH to Product Management Leader"

Tracing the journey from public health foundations to executive leadership in a 20-year career transforming healthcare delivery through technology.

Read the Profile